Integrated BioPharma Inc (INBP) shareholders
Close on Oct 19, 2026Market cap $5.59MP/E –Yield –
Ownership
Institutional holdings as of Sep 30, 2025, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| DeSantis Damon Joint filing with Cdds 2.0, LLC (41.00%) | 12,920,558 | 41.30% | 13D (active) | Apr 15, 2026 |
Top institutional holders
13F holdings as of Sep 30, 2025
| Holder | Shares | % of INBP | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Moloney Securities Asset Management, LLC | 20,000 | 0.06% | $5.80K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q3 2025 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2025 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2025 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2024 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2024 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2024 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2024 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2023 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2023 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2023 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2023 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2022 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Christina Kay | Co-Chief Executive Officer, Director, 10% owner | 4,883,979 | 15.72% | Dec 10, 2025 |
| Sheppard Riva | Co-Chief Executive Officer, 10% owner | 4,899,679 | 15.78% | Dec 10, 2025 |
| Dina Masi | Chief Financial Officer | 347,200 | 1.12% | Dec 10, 2025 |
| Robert Canarick | Director | 234,233 | 0.75% | Jun 25, 2026 |
| William H. Milmoe | Director | 2,512,751 | 8.09% | Jun 25, 2026 |
| Damon DeSantis | Director, 10% owner | 10,497,641 | 33.80% | Jun 25, 2026 |
| Eric J. Friedman | Director | 0 | – | Jun 25, 2026 |
| Carl Desantis | 10% owner | 2,352,826 | 7.58% | Apr 17, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Damon DeSantis Director, 10% owner | Apr 15, 2026 | Gift | +8,966,547 | – | – | 10,497,641 |
| Damon DeSantis Director, 10% owner | Apr 15, 2026 | Gift | +2,235,417 | – | – | 12,733,058 |
| Carl Desantis 10% owner | Apr 15, 2026 | Gift | −8,966,547 | – | – | 2,235,417 |
| Carl Desantis 10% owner | Apr 15, 2026 | Gift | −2,235,417 | – | – | 0 |
| William H. Milmoe Director | Apr 15, 2026 | Gift | −2,235,417 | – | – | 138,667 |
| William H. Milmoe Director | Apr 15, 2026 | Gift | −8,966,547 | – | – | 2,374,084 |
| William H. Milmoe Director | Apr 15, 2026 | Gift | −2,235,417 | – | – | 138,667 |
| William H. Milmoe Director | Apr 15, 2026 | Gift | −8,966,547 | – | – | 2,374,084 |
| Carl Desantis 10% owner | Mar 24, 2026 | Gift | −1,356,293 | – | – | 11,374,065 |
| Carl Desantis 10% owner | Mar 24, 2026 | Gift | −7,392 | – | – | 11,366,673 |
| William H. Milmoe Director, 10% owner | Mar 24, 2026 | Gift | −1,356,293 | – | – | 11,512,732 |
| William H. Milmoe Director, 10% owner | Mar 24, 2026 | Gift | −7,392 | – | – | 11,505,340 |
| Damon DeSantis Director | Mar 24, 2026 | Gift | +7,392 | – | – | 1,363,685 |
| Damon DeSantis Director | Mar 24, 2026 | Gift | +1,356,293 | – | – | 1,356,293 |
| William H. Milmoe Director, 10% owner | May 30, 2025 | Award | +50,000 | $0.09 | $4.50K | 138,667 |
| Robert Canarick Director | May 21, 2025 | Award | +175,000 | $0.09 | $15.75K | 234,233 |
| Dina Masi Chief Financial Officer | May 21, 2025 | Award | +135,000 | $0.09 | $12.15K | 347,200 |
| Sheppard Riva Co-Chief Executive Officer, Director, 10% owner | May 21, 2025 | Award | +144,445 | $0.09 | $13.00K | 1,473,467 |
| Christina Kay Co-Chief Executive Officer, Director, 10% owner | May 21, 2025 | Award | +144,445 | $0.09 | $13.00K | 1,473,467 |
| Dina Masi Chief Financial Officer | Nov 25, 2024 | Award | +65,000 | $0.09 | $5.85K | 212,200 |
| Sheppard Riva Co-Chief Executive Officer, Director, 10% owner | Nov 25, 2024 | Award | +55,555 | $0.09 | $5.00K | 1,329,022 |
| Christina Kay Co-Chief Executive Officer, Director, 10% owner | Nov 25, 2024 | Award | +55,555 | $0.09 | $5.00K | 1,329,022 |
| Dina Masi Chief Financial Officer | Sep 20, 2023 | Award | +50,000 | $0.09 | $4.50K | 147,200 |
| Sheppard Riva Co-Chief Executive Officer, Director, 10% owner | Sep 20, 2023 | Award | +50,000 | $0.09 | $4.50K | 1,273,467 |
| Christina Kay Co-Chief Executive Officer, Director, 10% owner | Sep 20, 2023 | Award | +50,000 | $0.09 | $4.50K | 1,273,467 |
| Christina Kay Co-Chief Executive Officer, Director | May 30, 2023 | Gift | +50,000 | $0.34 | $17.00K | 1,811,800 |
| Sheppard Riva Co-Chief Executive Officer, Director | May 30, 2023 | Gift | +50,000 | $0.34 | $17.00K | 1,811,800 |
| Sheppard Riva Co-Chief Executive Officer, Director, 10% owner | May 25, 2023 | Award | +3,410,512 | $0.40 | $1.36M | 3,426,212 |
| Christina Kay Co-Chief Executive Officer, Director, 10% owner | May 25, 2023 | Award | +3,410,512 | $0.40 | $1.36M | 3,410,512 |
| E. Gerald Kay Executive Chairman & President, Director, 10% owner | Mar 20, 2023 | Inheritance | −853,022 | – | – | 0 |
| E. Gerald Kay Executive Chairman & President, Director, 10% owner | Mar 20, 2023 | Inheritance | −4,299,533 | – | – | 0 |
| E. Gerald Kay Executive Chairman & President, Director, 10% owner | May 6, 2022 | Option exercise | +100,000 | $0.23 | $23.00K | 5,345,889 |
| E. Gerald Kay Executive Chairman & President, Director, 10% owner | May 6, 2022 | Award | +100,000 | $0.23 | $23.00K | 5,345,889 |
| E. Gerald Kay Chief Executive Officer, Director, 10% owner | Dec 19, 2018 | Award | +100,000 | $0.10 | $10.00K | 5,262,556 |
| Sheppard Riva Executive Vice President, Director | Dec 19, 2018 | Award | +50,000 | $0.14 | $7.00K | 1,423,467 |
| Sheppard Riva Executive Vice President, Director | Dec 19, 2018 | Award | +50,000 | $0.14 | $7.00K | 1,173,467 |
| Christina Kay Executive Vice President, Director | Dec 19, 2018 | Award | +50,000 | $0.14 | $7.00K | 1,423,467 |
| Christina Kay Executive Vice President, Director | Dec 19, 2018 | Award | +50,000 | $0.14 | $7.00K | 1,173,467 |
| CD Financial, LLC 10% owner | Jul 31, 2018 | Other | +8,230,769 | $0.65 | $5.35M | 10,524,173 |
| William H. Milmoe Director, 10% owner | Jul 31, 2018 | Other | +8,230,769 | $0.65 | $5.35M | 188,667 |
| Carl Desantis Director, 10% owner | Jul 31, 2018 | Other | +8,230,769 | $0.65 | $5.35M | 117,409 |
| E. Gerald Kay CEO AND PRESIDENT, Director, 10% owner | Jun 27, 2012 | Sale | −250,000 | $0.09 | $22.50K | 5,270,444 |
| CD Financial, LLC 10% owner | May 21, 2012 | Other | +50,000 | – | – | 4,456,293 |
| William H. Milmoe Director, 10% owner | May 21, 2012 | Other | +50,000 | – | – | 4,582,960 |
| Carl Desantis Director, 10% owner | May 21, 2012 | Other | +50,000 | – | – | 6,771,011 |
| CD Financial, LLC 10% owner | Feb 21, 2012 | Other | +50,000 | – | – | 4,406,293 |
| William H. Milmoe Director, 10% owner | Feb 21, 2012 | Other | +50,000 | – | – | 4,532,960 |
| Carl Desantis Director, 10% owner | Feb 21, 2012 | Other | +50,000 | – | – | 6,721,011 |
| CD Financial, LLC 10% owner | Nov 21, 2011 | Other | +50,000 | – | – | 4,356,293 |
| William H. Milmoe Director, 10% owner | Nov 21, 2011 | Other | +50,000 | – | – | 4,482,960 |
| Carl Desantis Director, 10% owner | Nov 21, 2011 | Other | +50,000 | – | – | 6,671,011 |
| CD Financial, LLC 10% owner | Aug 21, 2011 | Other | +50,000 | – | – | 4,306,293 |
| William H. Milmoe Director, 10% owner | Aug 21, 2011 | Other | +50,000 | – | – | 4,432,960 |
| Carl Desantis Director, 10% owner | Aug 21, 2011 | Other | +50,000 | – | – | 6,621,011 |
| CD Financial, LLC 10% owner | May 21, 2011 | Other | +50,000 | – | – | 4,256,293 |
| William H. Milmoe Director, 10% owner | May 21, 2011 | Other | +50,000 | – | – | 4,382,960 |
| Carl Desantis Director, 10% owner | May 21, 2011 | Other | +50,000 | – | – | 6,571,011 |
| CD Financial, LLC 10% owner | Feb 21, 2011 | Other | +50,000 | – | – | 4,206,293 |
| William H. Milmoe Director, 10% owner | Feb 21, 2011 | Other | +50,000 | – | – | 4,332,960 |
| Carl Desantis Director, 10% owner | Feb 21, 2011 | Other | +50,000 | – | – | 6,521,011 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Integrated BioPharma's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?